A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Pfizer
3B Pharmaceuticals GmbH
NuCana plc
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Pfizer
Seagen Inc.
Seagen Inc.
Sotio Biotech Inc.
Shanghai PerHum Therapeutics Co., Ltd.
Inhibrx Biosciences, Inc
ADC Therapeutics S.A.
University of Florida
Fusion Pharmaceuticals Inc.
pharmaand GmbH
Fate Therapeutics
Genmab
Nouvelle Clinique Bonnefon
Incyte Corporation
KitovPharma
CureOne
SWOG Cancer Research Network
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
Auron Healthcare GmbH